{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:31:40Z","timestamp":1791181900113,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ncl.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T09:15:44Z","timestamp":1374138944000},"page":"1085-1094","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Neurogenetics"],"prefix":"10.1016","volume":"31","author":[{"given":"Yvette M.","family":"Bordelon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2013.05.004_bib1","first-page":"317","article-title":"On chorea","volume":"789","author":"Huntington","year":"1872","journal-title":"The Medical and Surgical Reporter"},{"key":"10.1016\/j.ncl.2013.05.004_bib2","series-title":"Therapeutics of Parkinson\u2019s disease and other movement disorders","first-page":"295","article-title":"Huntington\u2019s disease","author":"Biglan","year":"2008"},{"key":"10.1016\/j.ncl.2013.05.004_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000331912","article-title":"Huntington\u2019s disease: current epidemiology and pharmacological management in UK primary care","volume":"37","author":"Sackley","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ncl.2013.05.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/j.ncl.2013.05.004_bib5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/appi.neuropsych.22.2.196","article-title":"\u201cFrontal\u201d behaviors before the diagnosis of Huntington\u2019s disease and their relationship to markers of disease progression: evidence of early lack of awareness","volume":"22","author":"Duff","year":"2010","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.ncl.2013.05.004_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2013.05.004_bib7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/mds.22953","article-title":"Cognitive and functional decline in Huntington\u2019s disease: dementia criteria revisited","volume":"25","author":"Peavy","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2013.05.004_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1176\/appi.neuropsych.17.4.496","article-title":"Depression and stages of Huntington\u2019s disease","volume":"17","author":"Paulsen","year":"2005","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.ncl.2013.05.004_bib9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1176\/appi.ajp.162.4.725","article-title":"Critical periods of suicide risk in Huntington\u2019s disease","volume":"162","author":"Paulsen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ncl.2013.05.004_bib10","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/mds.23337","article-title":"Challenges assessing clinical end points in early Huntington disease","volume":"25","author":"Paulsen","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2013.05.004_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ncl.2013.05.004_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2013.05.004_bib13","first-page":"1202","article-title":"The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size","volume":"60","author":"Brinkman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2013.05.004_bib14","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2013.05.004_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.ncl.2013.05.004_bib16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ncl.2013.05.004_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2013.05.004_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.biopsych.2011.07.030","article-title":"Striatal volume contributes to the prediction of onset of Huntington disease in incident cases","volume":"71","author":"Aylward","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ncl.2013.05.004_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2013.05.004_bib20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2013.05.004_bib21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington\u2019s disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J\u00a0Chem Neuroanat"},{"key":"10.1016\/j.ncl.2013.05.004_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(03)00317-X","article-title":"Predictive testing for Huntington\u2019s disease: a universal model?","volume":"2","author":"Hayden","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2013.05.004_bib23","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/01.WNL.0000032255.75650.C2","article-title":"Presymptomatic testing in Huntington\u2019s disease and autosomal dominant cerebellar ataxias","volume":"59","author":"Goizet","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.05.004_bib24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.ejhg.5201291","article-title":"New tools for preimplantation genetic diagnosis of Huntington\u2019s disease and their clinical applications","volume":"12","author":"Moutou","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ncl.2013.05.004_bib25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/jmg.39.7.522","article-title":"Predictive testing in the context of pregnancy: experience in Huntington\u2019s disease and autosomal dominant cerebellar ataxia","volume":"39","author":"Lesca","year":"2002","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ncl.2013.05.004_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.ejhg.5201774","article-title":"The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation","volume":"15","author":"Decruyenaere","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ncl.2013.05.004_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.23953","article-title":"Pharmacologic approaches to the treatment of Huntington\u2019s disease","volume":"27","author":"Venuto","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2013.05.004_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11940-012-0165-x","article-title":"Therapeutics in Huntington\u2019s disease","volume":"14","author":"Killoran","year":"2012","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ncl.2013.05.004_bib29","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1212\/WNL.0b013e318263c443","article-title":"Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease","volume":"79","author":"Armstrong","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.05.004_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized control trial","volume":"66","author":"Huntington Study Group","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.05.004_bib31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1212\/WNL.59.5.694","article-title":"Huntington\u2019s disease: a randomized, controlled trial using the NMDA-antagonist amantadine","volume":"59","author":"Verhagen Metman","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2013.05.004_bib32","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneur.60.7.996","article-title":"A\u00a0randomized trial of amantadine in Huntington disease","volume":"60","author":"O\u2019Suilleabhain","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2013.05.004_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/YIC.0b013e3283348018","article-title":"Combating depression in Huntington disease: effective antidepressive treatment with venlafaxine XR","volume":"25","author":"Holl","year":"2010","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.ncl.2013.05.004_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archneurol.2009.180","article-title":"Progress and challenges in RNA interference therapy for Huntington disease","volume":"66","author":"Harper","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2013.05.004_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington\u2019s disease 6 years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-Levi","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2013.05.004_bib36","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.0904239106","article-title":"Neural transplants in patients with Huntington\u2019s disease undergo disease-like neuronal degeneration","volume":"106","author":"Cicchetti","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2013.05.004_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mcn.2013.02.005","article-title":"Modeling Huntington\u2019s disease with induced pluripotent stem cells","volume":"56C","author":"Kaye","year":"2013","journal-title":"Mol Cell Neurosci"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861913000613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861913000613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T13:50:05Z","timestamp":1539525005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861913000613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0733861913000613"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2013.05.004","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}